Revisiting the IGF-1R as a breast cancer target
Abstract The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth fa...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/ff753cb1f1364c4681fe4a6c2ca7b956 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|